Sickle cell anemia-sicle_cell_anemia

- sicklecell anemia

Here is an article on Sickle cell anemia-sicle_cell_anemia.

Sickle cell anemia-sicle_cell_anemia

Sickle-cell Anemia Classifications and external sicle cell anemia resources Sickle-shaped red blood cells ICD-10 D57. ICD-9 282.6 OMIM 603903 DiseasesDB 1206 MedlinePlus 000527 eMedicine emerg/26  MeSH C15.378.071.141.150.150 Sickle-cell disease is sicklecell anemia a general term for a group of genetic disorders caused by sickle hemoglobin (Hgb S or Hb S). In many forms of the disease, sickle cell anmia the red blood sickle cell enemia cells change shape, usually looking much like that of a banana, upon deoxygenation because of polymerization of the abnormal sickle hemoglobin. This sickle cell anemis process damages the red blood cell sickle cel anemia membrane, and can cause the cells to become stuck in blood vessels. This deprives the downstream tissues of oxygen and causes ischemia and sickle cell anemoa infarction. The disease is chronic and lifelong. Individuals are most often well, but sickle cell anamia their lives are punctuated by periodic painful attacks. In addition to periodic pain, there may sickl cell anemia be damage of sickle cell amemia internal organs, such as stroke. Lifespan is often shortened with sufferers living to an average sickle cell anemia of 40 years. Sickle-cell disease occurs more commonly in people (or their descendants) from parts of the world, such as sub-Saharan Africa, where malaria is or history of sickle cell anemia was common. Sickle-cell congestive heart failure in sickle cell anemia disease can occur in any individual of any color or ethnicity, however. Contents 1 Types and terminology 2 Signs holistic care for sickle cell anemia and symptoms 2.1 Vaso-occlusive crises 2.2 Other teachers and sickle cell anemia sickle-cell crises 2.3 Complications 3 Diagnosis 4 Pathophysiology 5 Genetics 5.1 Inheritance 5.1.1 Examples 6 Treatment 6.1 Febrile what is sickle cell anemia sickle cell anemia video clip recent study for sickle cell anemia illness 6.2 Painful (vaso-occlusive) crises 6.3 Acute sickle cell anemia black chest crises 6.4 Hydroxyurea 6.5 Future treatments 7 Situation of carriers 8 History 9 See sickle cell anemia in children information services also 10 Notes 11 References 12 External links Types and terminology "Sickle-cell anemia" is the name of a specific form of sickle-cell sickle cell anemia crisis treatment disease in which there is homozygosity for the mutation cause of sickle cell anemia that causes Hgb S. Other forms of sickle-cell genetic testing for sickle cell anemia disease include: sickle-haemoglobin C disease sickle beta-plus-thalassemia sickle beta-zero-thalassemia hemoglobin ss Unlike sickle-cell anemia, these other forms of medical journals on sickle cell anemia sickle-cell disease are compound heterozygous states in which the person has only one copy of the hydroxurea and sickle cell anemia mutation that causes Hgb S and one copy of another abnormal haemoglobin gene. It is important to know that "sickle-cell anemia" money for children with sickle cell anemia for christmas is the proper name of a specific type of sickle cell anemia and pregnancy "sickle-cell disease", and that "sickle-cell disease" is a non-specific treatment for sickle cell anemia term. Because the different forms of sickle-cell disease are quite different, one must be sure to specify anemia blood cell duffy group sickle system the exact form of the disease in question. Signs and symptoms Patients with sickle cell children with sickle cell anemia anaemia have an anaemia that varies in severity, with typical hemoglobin levels of facts for teachers about sickle cell anemia 6-9 g/dl. Reticulocyte counts are elevated, reflecting new red blood cells replacing famous people with sickle cell anemia the rapidly destroyed older cells - red blood cell life span is markedly reduced in this disease. Often, the white foundations for sickle cell anemia blood cell and platelet counts are medications for sickle cell anemia elevated, and these cells may contribute to vaso-occlusion. Vaso-occlusive crises A vaso-occlusive crisis is caused by sickle-shaped red blood people with sickle cell anemia cells that obstruct capillaries and restrict bloodflow to an organ, resulting in ischemia, pain, percent of carriers sickle cell anemia africa and organ damage. Because of its narrow vessels and function in clearing defective red blood cells, the spleen is frequently affected. pictures of sickle cell anemia blood cells It is usually infarcted before pictures of sickle cell anemia cells the end of childhood in individuals suffering from sickle-cell anemia. This autosplenectomy increases the risk of infection from sickle cell anemia and sickle cell crisis encapsulated organisms; preventive antibiotics and vaccinations sickle cell anemia antioxidants are recommended for those with such asplenia. Liver failure may also occur with time. Bones, especially weight-bearing bones, sickle cell anemia graphs are also a common target of vasoocclusive damage. Such damage may result -cell patients is also due to the bone ischemia. A recognized sickle cell anemia punnett square type of sickle sickle cell anemia resistance to malaria crisis is the acute chest crisis, a condition characterized by fever, chest pain, hard breathing, and pulmonary infiltrate on chest X-ray. Given that pneumonia and intra-pulmonary the cause of sickle cell anemia sickling can the history of sickle cell anemia both produce these symptoms, the patient is treated for both conditions. Treatment consists of admission, babies with sickle cell anemia oxygen, close monitoring, and intravenous antibiotics. Other sickle-cell crises Aplastic crisis. An acute worsening of the patient's baseline anemia producing pallor, tachycardia, and fatigue. This black panthers sickle cell anemia program crisis is causes of sickle cell anemia triggered by parvovirus B19, which directly affects erythropoiesis (production of red blood cells). Reticulocyte counts drop dramatically during the illness and the rapid education and sickle cell anemia turnover of red cells leads to the drop in hemoglobin. Most patients can be managed evolution of sickle cell anemia supportively; some need blood transfusion. Splenic sequestration crisis. An grants for children with sickle cell anemia acute, painful enlargement of the spleen. The abdomen becomes bloated and very hard. Management is supportive, sometimes with information on sickle cell anemia blood transfusion. Complications Sickle-cell anemia can lead to various is there a cure for sickle cell anemia complications, including: Vaso-occlusive crisis (otherwise known as pain crisis): Most patients with sickle cell disease have periodic intensely new studies for sickle cell anemia painful episodes called vaso-occlusive crises. The frequency, severity, and duration of these crises vary tremendously. Painful crises pain assessment in sickle cell anemia patients are treated with hydration and analgesics; pain management requires opioid administration at regular pictures of sickle cell anemia intervals until the crisis has settled. For milder platelets sickle cell anemia crises a subgroup of patients manage on NSAIDs (such as diclofenac or naproxen). sickle cell anemia afro-american For more severe crises most patients require inpatient management for intravenous opioids; patient-controlled analgesia (PCA) devices are commonly used in this setting. Diphenhydramine sickle cell anemia jewish is effective for the itching associated with the opioid use. sickle cell anemia picture Incentive spirometry, a technique to encourage deep breathing to minimize the development of atelectasis, is sickle cell anemia science article recommended. Overwhelming post-(auto)splenectomy infection - due to functional stigmas sickle cell anemia asplenia, caused by encapsulated organisms such as Streptococcus pneumoniae and Haemophilus influenzae. Daily penicillin prophylaxis is the most commonly used treatment during childhood symptoms of sickle cell anemia with some hematologists continuing treatment indefinitely. affect on fetus with sickle cell anemia Patients benefit today from routine vaccination for Haemophilus influenzae, Pneumococcus and Meningococcus. Stroke - progressive vascular anemia cell sickle trait narrowing (occlusion) can prevent oxygen from reaching the brain, leading to stroke; cerebral black panthers and sickle cell anemia infarction occurs in children, and cerebral hemorrhage in adults. Cholelithiasis and cholecystitis (gallstones) - prolonged hemolysis may lead to excessive bilirubin production bunchy carter free clinic sickle cell anemia and precipitation, leading to gallstones Avascular necrosis celebrities with sickle cell anemia (aseptic bone necrosis) of the hip Decreased immune reactions due to hyposplenism (malfunctioning of the spleen) Priapism and infarction of the penis child with sickle cell anemia (in men) Osteomyelitis (bacterial bone infection) - salmonella is noted cures for sickle cell anemia much more commonly than in the general population, but staphylococcus is still the most description of sickle cell anemia common pathogen. Opioid addiction (see below) Diagnosis Attacks are diagnosed clinically, i.e. there is no gold standard diagnostic test. Hemolysis (anemia and diagnosis of sickle cell anemia jaundice) is often discharge instructions for sickle cell anemia patient present, although for painful crises the diagnosis depends essentially on how the patient describes the pain. Abnormal hemoglobin distribution of sickle cell anemia forms are detected on hemoglobin electrophoresis, a form of gel electrophoresis on which the various types of hemoglobin move at facts about sickle cell anemia varying speed. Sickle cell hemoglobin facts on sickle cell anemia (HbSS) and Hemoglobin C with sickling (HbSC)—the two most common forms—can be identified from there. Genetic testing is rarely genetics and sickle cell anemia performed. Pathophysiology Sickle-cell anemia is caused by a missense mutation in the β-globin chain of how is sickle cell anemia diagnosed hemoglobin, replacing the amino acid glutamic acid with the how many women have sickle cell anemia less polar amino acid valine at the sixth position of the β human genetics and sickle cell anemia chain . The association of two wild type α-globin subunits with two mutant β-globin subunits forms hemoglobin S, malaria sickle cell anemia which polymerises under low oxygen conditions causing distortion of red blood cells and a tendency for pain and sickle cell anemia them to lose their elasticity. New erythrocytes are quite elastic, which allows the cells to deform to pass through pictures of sickle cell anemia that is in the bloodstream capillaries. Often a cycle occurs because as the cells sickle, they cause a region pictures sickle cell anemia of low oxygen concentration which causes more red blood cells to sickle. Repeated episodes of sickling causes loss pie graghs showing results of sickle cell anemia of this elasticity and the cells fail research on sickle cell anemia to return to normal shape when oxygen concentration increases. These rigid red blood research paper on sickle cell anemia cells are unable to flow through narrow capillaries, causing vessel occlusion sickle cell anemia 20 questions and ischemia. Genetics Sickle-cell disease is inherited in the autosomal recessive pattern, depicted sickle cell anemia 78h nucleotide mutation above. The allele responsible for sickle cell anemia sickle cell anemia 7th nucleotide mutation is autosomal recessive. A person who receives the defective gene from both father and mother develops the disease; a person who receives one sickle cell anemia 8th nucleotide mutation defective and one healthy allele remains sickle cell anemia and diagnosis healthy, but can pass on the disease and is known as a carrier. If two sickle cell anemia and low hemoglobin parents who are carriers have a child, there is a 1-in-4 chance of their child developing the illness sickle cell anemia and malaria and a 1-in-2 chance of their child just being a carrier. The gene defect sickle cell anemia and pathologist is a known mutation of a single nucleotide (A to T) of the β-globin gene, which sickle cell anemia and teachers results in glutamic acid to be substituted by valine at position 6. Hemoglobin S with this mutation sickle cell anemia and therapy are referred to as HbS, sickle cell anemia best as opposed to the normal adult HbA. The genetic disorder is due to the mutation of a single nucleotide, from a GAG sickle cell anemia black illness to GTG codon mutation. This is normally a sickle cell anemia gel electrophoresis benign mutation, causing no apparent effects on the secondary, tertiary, or quaternary structure of hemoglobin. What sickle cell anemia genotype it does allow for, under conditions of sickle cell anemia groups low oxygen concentration, is the polymerization of the HbS itself. The deoxy form of hemoglobin sickle cell anemia hydroxyurea exposes a hydrophobic patch on the protein between the E and F helices. The hydrophobic residues of the valine at position sickle cell anemia in african americans 6 of the beta chain in hemoglobin are able to sickle cell anemia in children bind to the hydrophobic patch, causing hemoglobin S molecules to aggregate and form fibrous precipitates. In people heterozygous for HbS (carriers sickle cell anemia info of sickling hemoglobin), the polymerization problems are minor. In people homozygous sickle cell anemia integration for HbS, the presence of long chain polymers of HbS distort the shape of the sickle cell anemia laboratory red blood cell, from a smooth donut-like shape sickle cell anemia nucleotide mutation to ragged and full of spikes, making it fragile and susceptible to breaking within capillaries. Carriers only have symptoms if they sickle cell anemia pittsburgh are deprived of oxygen (for example, while climbing a mountain) or while severely dehydrated. sickle cell anemia prognosis For those afflicted with the disease, however, vasocclusive events can be a sickle cell anemia recent study painful part of life (normally they occur 0.8 sickle cell anemia support group florida times per year per patient). This occurs when HbS becomes deoxygenated it undergoes an abnormal change in sickle cell anemia t cell lymphoma shape and consistency which can lead to a change in the shape sickle cell anemia trait and plasticity in the cell wall of the RBC, an occurrence called sickling. The sufferers sickle cell anemia trements of the illness have a reduced life span. It is believed that carriers (sickle cell trait) are relatively resistant to malaria. Since the gene sickle cell anemia wish granting foundations is incompletely recessive, carriers have a few sickle red blood cells statistics on sickle cell anemia at all times, not enough to cause symptoms, but enough teaching a child with sickle cell anemia to give resistance to malaria. Because of this, heterozygotes have a higher fitness than either of transversion sickle cell anemia the homozygotes. This is known as heterozygote advantage. The malaria parasite has a complex life cycle and spends part of treatments for sickle cell anemia it in red blood treatments of sickle cell anemia cells. In a carrier, the presence of the malaria parasite causes the red blood cell to rupture, making the plasmodium unable to reproduce. Further, types of mutation sickle cell anemia the polymerization of Hb affects types of sickle cell anemia the ability of the parasite to digest Hb in the first place. Therefore, in areas where malaria is a problem, people's chances what causes sickle cell anemia of survival actually increase if they carry sickle what is bottlenecking effect in sickle cell anemia cell trait (selection for the heterozygote). Due to what is the cause of sickle cell anemia the above phenomenon, the illness is still prevalent, especially among people with recent ancestry in malaria-stricken areas, such as Africa, the Mediterranean, India and the who discovered sickle cell anemia treatment Middle East. In fact, sickle-cell anemia is the most common genetic disorder among African why is sickle cell anemia more common in african americans Americans; about 1 in every 12 is a carrier. The evolution of sickle-cell anaemia is probably an with sickle cell anemia example of Baldwinian evolution, whereby humans modify their environment and thus change the selective pressures. As humans in tropical areas in Africa and elsewhere developed agriculture and animal husbandry, they expanded the niche for Anopheles mosquitoes that could transmit the malaria parasite. In the USA, where there is no endemic malaria, the incidence of sickle cell anaemia amongst African Americans is much lower than in West Africa and falling. Without endemic malaria from Africa, the condition is purely disadvantageous, and will tend to be bred out of the affected population. See the Price equation article for a simplified mathematical model of the genetic evolution of sickle cell anemia. Inheritance Sickle cell conditions are inherited from parents in much the same way as blood type, hair color and texture, eye color and other physical traits. The types of hemoglobin a person makes in the red blood cells depend upon what hemoglobin genes the person inherits from his or her parents. Like most genes, hemoglobin genes are inherited in two sets, one from each parent. Examples If one parent has Sickle Cell Anemia ("rr" in the diagram above) and the other is Normal (RR), all of their children will have sickle cell trait (Rr). If one parent has Sickle Cell Anemia (rr) and the other has Sickle Cell Trait (Rr), there is a 50% chance (or 1 out of 2) of a child having sickle cell disease (rr) and a 50% chance of a child having sickle cell trait (Rr). When both parents have Sickle Cell Trait (Rr), they have a 25% chance (1 of 4) of a child having sickle cell disease (rr), as shown in the diagram above. Treatment Febrile illness Children with fever are screened for bacteremia i.e. complete blood count, reticulocyte count and blood culture taken. Younger children (varies from center to center) are admitted for intravenous antibiotics while older children with reassuring white cell counts are managed at home with oral antibiotics. Children with previous bacteremic episodes should be admitted. Painful (vaso-occlusive) crises Most patients with sickle cell disease have intensely painful episodes called vaso-occlusive crises. The frequency, severity, and duration of these crises vary tremendously, however. Painful crises are treated symptomatically with analgesics; pain management requires opioid administration at regular intervals until the crisis has settled. For milder crises a subgroup of patients manage on NSAIDs (such as diclofenac or naproxen). For more severe crises most patients require inpatient management for intravenous opioids; patient-controlled analgesia (PCA) devices are commonly used in this setting. Diphenhydramine is effective for the itching associated with the opioid use. Acute chest crises Management is similar to vaso-occlusive crises with the addition of antibiotics (usually a third generation cephalosporin), oxygen supplementation for hypoxia, and close observation. Should the pulmonary infiltrate worsen or the oxygen requirements increase, simple blood transfusion or exchange transfusion is indicated. The latter involves the exchange of a significant portion of the patients red cell mass for normal red cells, which decreases the percent hemoglobin S in the patient's blood. Hydroxyurea The first approved drug for the causative treatment of sickle cell anemia, hydroxyurea, was shown to decrease the number and severity of attacks in a study in 1995 (Charache et al) and shown to increase survival time in a study in 2003. This is achieved by reactivating fetal hemoglobin production in place of the hemoglobin S that causes sickle cell anaemia. Hydroxyurea had previously been used as a chemotherapy agent, and there is some concern that long-term use may be harmful, but it is likely that the benefits outweigh the risks. Future treatments Various approaches are being sought for preventing sickling episodes as well as for the complications of sickle-cell disease. Other ways to modify Hb switching are being investigated, including the use of phytochemicals such as Nicosan. Gene therapy is under investigation. Situation of carriers People who are known carriers of the disease often undergo genetic counseling before they have a child. A test to see if an unborn child has the disease takes either a blood sample from the unborn or a sample of amniotic fluid. Since taking a blood sample from a fetus has risks, the latter test is usually used. After the mutation responsible for this disease was discovered in 1979, the U.S. Air Force required African American applicants to test for the mutation. It dismissed 143 applicants because they were carriers, even though none of them had the condition. It eventually withdrew the requirement, but only after a trainee filed a lawsuit. History The cause of this collection of clinical findings was unknown until the description of the sickle cells in 1910 by the Chicago cardiologist and professor of medicine James B. Herrick (1861-1954) whose intern Ernest Edward Irons (1877-1959) found "peculiar elongated and sickle shaped" cells in the blood of Walter Clement Noel, a 20 year old first year dental student from Grenada after Noel was admitted to the Presbyterian Hospital in December 1904 suffering from anemia. Noel was readmitted several times over the next three years for "muscular rheumatism" and "bilious attacks" while an undergraduate. Noel completed his studies and returned to capital of Grenada (St. George's) to practice dentistry. He died of pneumonia in 1916 and is buried in the Catholic cemetery at Sauteurs in the north of Grenada.[1] The disease is very occasionally called "Herrick's syndrome" for this reason. The disease was named "sickle cell anemia" by Vernon Mason in 1922. In retrospect some elements of the disease had been recognized earlier: a paper in the Southern Journal of Medical Pharmacology in 1846 described the absence of a spleen in the autopsy of a runaway slave. The African medical literature reported this condition in the 1870's where it was known locally as ogbanjes ('children who come and go') because of the very high infant mortality in this condition. And a history of the condition tracked reports back to 1670 in one Ghanian family.[2] Also, the practice of using tar soap to cover blemishes caused by sickle cell sores was prevalent in the African American community. The origin of the mutation that led to the sickle cell gene was initially thought to be in the Arabian peninsula, spreading to Asia and Africa. It is now known, from evaluation of chromosome structures, that there have been at least four independent mutational events, three in Africa and a fourth in either Saudi Arabia or central India.[3] These independent events occurred between 3000 and 6000 generations ago, approximately 70000-150000 years. See also Thalassemia Dominance relationships Genetic counseling Sickle cell trait Exchange transfusion Notes ^ Savitt TL, Goldberg MF. Herrick's 1910 case report of sickle cell anemia. The rest of the story. JAMA. 1989;261:266-271. PMID 2642320 ^ Konotey-Ahulu FID. Effect of environment on sickle cell disease in West Africa: epidemiologic and clinical considerations. In: Sickle Cell Disease, Diagnosis, Management, Education and Research. Abramson H, Bertles JF, Wethers DL, eds. CV Mosby Co, St. Louis. 1973; 20; cited in D. V. Desai, Hiren Dhanani: Sickle Cell Disease: History And Origin. The Internet Journal of Hematology. 2004. Volume 1 Number 2 ^ D. V. Desai, Hiren Dhanani: Sickle Cell Disease: History And Origin. The Internet Journal of Hematology. 2004. Volume 1 Number 2 (Banana) References Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22. PMID 12672732. Chestnut, D. (1994). Perceptions of ethnic and cultural factors in the delivery of services in the treatment of sickle cell disease. Journal of Health and Social Policy, 5(3/4), 236. External links Sickle Cell Anemia-Teens Health Sickle Cell (Sickle Cell Information Center) Sickle cell anemia research - Recent primary literature on sickle cell anemia SCA clinical trials (ClinicalTrials.gov) Sickle Cell Anemia (University of Maryland Medical Center) Sickle Cell links (NCBI)  v • d • e  Health science - Medicine - Hematology Hematological malignancy and White blood cells Lymphoid: Lymphocytic leukemia (ALL, CLL, HCL) | Lymphoma (Hodgkin's disease, NHL) | LPD | Myeloma (Multiple myeloma, Extramedullary plasmacytoma) Myeloid: Myelogenous leukemia (AML, CML) | MPD (Essential thrombocytosis, Polycythemia) | MDS | Myelofibrosis | Neutropenia Red blood cells Anemia | Hemochromatosis | Sickle-cell disease | Thalassemia | Hemolysis | Aplastic anemia | G6PD Deficiency | Hereditary spherocytosis | Hereditary elliptocytosis | Other hemoglobinopathies Coagulation and Platelets Thrombosis | Deep vein thrombosis | Pulmonary embolism | Hemophilia | ITP | TTP | DIC Search Term: "Sickle-cell_disease" Categories: Blood disorders | Genetic disorders

He's a sick young boy but he's full of life